Visualizing CTL/melanoma cell interactions: multiple hits must be delivered for tumour cell annihilation

被引:34
作者
Caramalho, Iris [1 ,3 ]
Faroudi, Mustapha
Padovan, Elisabetta [3 ,4 ]
Mueller, Sabina
Valitutti, Salvatore [2 ,3 ]
机构
[1] Ctr Physiopathol Toulouse Purpan, INSERM, Sect Dynam Mol Interact Lymphocytaires, U563, F-31300 Toulouse, France
[2] Univ Toulouse 3, F-31062 Toulouse, France
[3] Inst Gulbenkian Ciencias, Oeiras, Portugal
[4] Univ Lisbon, Fac Med, P-1200 Lisbon, Portugal
关键词
CTL; melanomas; cytotoxicity; immunological synapse; time-lapse microscopy; CYTOTOXIC T-LYMPHOCYTES; MELANOMA-CELLS; IMMUNOLOGICAL SYNAPSE; METASTATIC MELANOMA; IMMUNE ESCAPE; TARGET-CELL; LOW-AVIDITY; MECHANISM; CANCER; ACTIVATION;
D O I
10.1111/j.1582-4934.2008.00586.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
It is well established that cytotoxic T lymphocytes (CTL) can kill target cells offering a very small number of specific peptide/MHC complexes (pMHC). It is also known that lethal hit delivery is a very rapid response that occurs within a few minutes after cell-cell contact. Whether cytotoxicity is efficient and rapid in the context of CTL interaction with target cells derived from solid tumours is still elusive. We addressed this question by visualizing the dynamics of human CTL interaction with melanoma cells and their efficiency in eliciting cytotoxicity. Our results show that in spite of CTL activation to lethal hit delivery, killing of melanoma cells is not efficient. Time-lapse microscopy experiments demonstrate that individual CTL rapidly polarize their lytic machinery towards target cells, yet the apoptotic process in melanoma cells is defective or 'delayed' as compared to conventional targets. These results indicate that although CTL activation to lethal hit delivery can be viewed as a 'digital' phenomenon rapidly triggered by a few ligands, melanoma cell annihilation is an 'analogue' response requiring multiple hits and prolonged contact time.
引用
收藏
页码:3834 / 3846
页数:13
相关论文
共 42 条
[1]   Identification of target actin content and polymerization status as a mechanism of tumor resistance after cytolytic T lymphocyte pressure [J].
Abouzahr, S ;
Bismuth, G ;
Gaudin, C ;
Caroll, O ;
Van Endert, P ;
Jalil, A ;
Dausset, J ;
Vergnon, I ;
Richon, C ;
Kauffmann, A ;
Galon, J ;
Raposo, G ;
Mami-Chouaib, F ;
Chouaib, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) :1428-1433
[2]   Knock-down of Bcl-2 by antisense oligodeoxynucleotides induces radiosensitization and inhibition of angiogenesis in human PC-3 prostate tumor xenografts [J].
Anai, Satoshi ;
Goodison, Steve ;
Shiverick, Kathleen ;
Hirao, Yoshihiko ;
Brown, Bob D. ;
Rosser, Charles J. .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (01) :101-111
[3]   Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation [J].
Balaji, KN ;
Schaschke, N ;
Machleidt, W ;
Catalfamo, M ;
Henkart, PA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (04) :493-503
[4]   Human T cell responses against melanoma [J].
Boon, Thierry ;
Coulie, Pierre G. ;
Van den Eynde, Benoit J. ;
van der Bruggen, Pierre .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :175-208
[5]   Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice [J].
Breart, Beatrice ;
Lemaitre, Fabrice ;
Celli, Susanna ;
Bousso, Philippe .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (04) :1390-1397
[6]   Cleavage of Bcl-2 in oxidant- and cisplatin-induced apoptosis of human melanoma cells [J].
Del Bello, B ;
Valentini, MA ;
Zunino, F ;
Comporti, M ;
Maellaro, E .
ONCOGENE, 2001, 20 (33) :4591-4595
[7]   Cancer immunoediting: from immunosurveillance to tumor escape [J].
Dunn, GP ;
Bruce, AT ;
Ikeda, H ;
Old, LJ ;
Schreiber, RD .
NATURE IMMUNOLOGY, 2002, 3 (11) :991-998
[8]   Lytic versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction:: Manifestation of a dual activation threshold [J].
Faroudi, M ;
Utzny, C ;
Salio, M ;
Cerundolo, V ;
Guiraud, M ;
Müller, S ;
Valitutti, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14145-14150
[9]  
Gassara A, 2006, INT J ONCOL, V29, P155
[10]   Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions [J].
Gervois, N ;
Guilloux, Y ;
Diez, E ;
Jotereau, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2403-2407